Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
Journal of Cosmetic Dermatology (2018) Randomized, vehicle-controlled, N=60 2% topical cream, twice daily 12 weeks Hair density (hairs/cm²) +31.2 hairs/cm² vs +3.1 control p<0.001 Gold-standard design with objective pho…
Source: realpeptides.coComparison
GHK-Cu (topical) Copper-dependent collagen synthesis, angiogenesis, TGF-β modulation Small-scale human trials (N=23–30), no FDA approval 5.9% mean hair density increase at 12 weeks (Pickart 2007) Limited direct data. Su…
Source: realpeptides.coComparison
The route of administration significantly impacts GHK-Cu’s effectiveness for hair restoration. Both injectable and topical forms offer benefits, but understanding their differences helps optimize results. Injectable GHK…
Source: redfoxpeptides.isComparison
Standard aqueous serum 0.5–1.0% 6.0–7.0 Passive diffusion 30–45 days before degradation Low. Most products lack third-party purity verification Avoid unless refrigerated and used within 60 days of opening Liposomal seru…
Source: realpeptides.coComparison
GHK-Cu is available in both topical and injectable formats. For hair-specific applications, the delivery route matters — and the evidence strongly favors topical.
Source: thepeptidecatalog.comComparison
Finasteride is a 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT) — the primary hormonal driver of androgenetic alopecia. GHK-Cu does not address the DHT pathway. Published…
Source: thepeptidecatalog.comComparison
Minoxidil is a potassium channel opener that primarily increases blood flow to hair follicles and extends the anagen growth phase through vasodilation. It does not directly address dermal papilla cell signaling or folli…
Source: thepeptidecatalog.comComparison
Mechanism Wnt activation, TGF-beta1 suppression, VEGF, DPC survival Potassium channel opening, vasodilation, VEGF 5-alpha reductase inhibition, reduces scalp DHT ~60% FDA-approved for hair Yes (topical) Yes (oral) Topic…
Source: peptidesexplorer.comComparison
The delivery method determines how much GHK-Cu reaches the dermal papilla, which sits 3 to 4 mm below the scalp surface. Penetration to follicle depth is the rate-limiting factor for every protocol.
Source: peptidesexplorer.comComparison
Dermal Penetration (Topical) Moderate (Franz cell: 12% penetration at 24h) High (Franz cell: 22% penetration at 24h) AHK-Cu reaches follicular bulge more efficiently in topical protocols TGF-β Receptor Affinity High (IC…
Source: realpeptides.coComparison
0.05–0.1% Daily Optional Collagen synthesis upregulation via TGF-β pathway Minimal follicle diameter change; improved scalp dermal thickness Best for scalp health maintenance, not active hair growth 0.5–1.0% 5–7 days/we…
Source: realpeptides.coComparison
Researchers investigating GHK-Cu for dermatological applications use two primary delivery methods: topical formulations (creams, serums, microneedling solutions) and subcutaneous injections. Each route presents distinct…
Source: realpeptides.co